Monoclonal Antibodies in Immunodiagnosis and Immunotherapy appoints new Deputy Editor-in-Chief, Andrei Moroz, PhD
Mary Ann Liebert, Inc., is pleased that Andrei Moroz, PhD, has been appointed the new Deputy Editor-in-Chief of the bimonthly journal Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. Dr. Moroz is joining Cory Brooks, PhD, as part of the senior editorial leadership team for the journal.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy is a peer-reviewed venue for promoting and sharing research rooted in hybridoma technology. It aims at advancing the understanding of the biology and immunology that underscores the utility of antibodies as diagnostics and therapeutics. The journal publishes research on the biology of B cells, the production of antibodies in terms of antibody descriptions, antibody engineering innovations and their use in diagnosis and therapy.
“I am pleased to welcome Dr. Andrei Moroz to the editorial team as Deputy Editor. Dr. Moroz brings to the position a fresh perspective, combined with a breadth of research expertise in monoclonal antibodies. His contributions and service will be invaluable in ensuring the legacy of quality and innovative scientific publication associated with Monoclonal Antibodies in Immunodiagnosis and Immunotherapy,” said Dr. Brooks.
“It brings me much joy to assume the role as Deputy Editor-in-Chief of Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (formerly Hybridoma). Antibodies are tools that reformed knowledge and will always contribute to new achievements in science. I look forward to working with Dr. Brooks and invite colleagues around the globe to send us submissions BLURB from Andrei being positive about the opportunity,” said Dr. Moroz.
Dr. Andrei Moroz is an Assistant Professor in the School of Pharmaceutical Sciences at São Paulo State University (UNESP). He completed his PhD in Applied Cell and Structural Biology at UNESP. His research focus is on tissue engineering, extracellular matrices and monoclonal antibody production and characterization.
Mary Ann Liebert, Inc., would like to thank Dr. Thomas Kieber-Emmons for his many years of dedication and service to the journal.
About the Journal
Credit: Mary Ann Liebert, Inc.
Mary Ann Liebert, Inc., is pleased that Andrei Moroz, PhD, has been appointed the new Deputy Editor-in-Chief of the bimonthly journal Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. Dr. Moroz is joining Cory Brooks, PhD, as part of the senior editorial leadership team for the journal.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy is a peer-reviewed venue for promoting and sharing research rooted in hybridoma technology. It aims at advancing the understanding of the biology and immunology that underscores the utility of antibodies as diagnostics and therapeutics. The journal publishes research on the biology of B cells, the production of antibodies in terms of antibody descriptions, antibody engineering innovations and their use in diagnosis and therapy.
“I am pleased to welcome Dr. Andrei Moroz to the editorial team as Deputy Editor. Dr. Moroz brings to the position a fresh perspective, combined with a breadth of research expertise in monoclonal antibodies. His contributions and service will be invaluable in ensuring the legacy of quality and innovative scientific publication associated with Monoclonal Antibodies in Immunodiagnosis and Immunotherapy,” said Dr. Brooks.
“It brings me much joy to assume the role as Deputy Editor-in-Chief of Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (formerly Hybridoma). Antibodies are tools that reformed knowledge and will always contribute to new achievements in science. I look forward to working with Dr. Brooks and invite colleagues around the globe to send us submissions BLURB from Andrei being positive about the opportunity,” said Dr. Moroz.
Dr. Andrei Moroz is an Assistant Professor in the School of Pharmaceutical Sciences at São Paulo State University (UNESP). He completed his PhD in Applied Cell and Structural Biology at UNESP. His research focus is on tissue engineering, extracellular matrices and monoclonal antibody production and characterization.
Mary Ann Liebert, Inc., would like to thank Dr. Thomas Kieber-Emmons for his many years of dedication and service to the journal.
About the Journal
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy is a peer-reviewed venue for promoting and sharing research rooted in hybridoma technology. It aims at advancing the understanding of the biology and immunology that underscores the utility of antibodies as diagnostics and therapeutics. Tables of content and a free sample issue may be viewed on the Monoclonal Antibodies in Immunodiagnosis and Immunotherapy website.
About the Publisher
Mary Ann Liebert, Inc., publishers is known for establishing authoritative peer-reviewed journals in many areas of science and biomedical research. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 90 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.
